Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients
Nowadays neoadjuvant immunotherapy is one of the main research areas in oncology. This interest is supported by the success of check-point inhibitors in treatment of advanced and metastatic lung cancer. The postulate that neoadjuvant immunotherapy achieves tumor devitalization before surgery is conf...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Russo |
| Gepubliceerd in: |
Remedium Group LLC
2019-12-01
|
| Reeks: | Медицинский совет |
| Onderwerpen: | |
| Online toegang: | https://www.med-sovet.pro/jour/article/view/5047 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|